Claims for Patent: 4,879,303
✉ Email this page to a colleague
Summary for Patent: 4,879,303
| Title: | Pharmaceutically acceptable salts |
| Abstract: | Improved pharmaceutical salts of amlodipine, particularly the besylate salt, and pharmaceutical compositions thereof. These salts find utility as anti-ischaemic and anti-hypertensive agents. |
| Inventor(s): | Davison; Edward (Margate, GB2), Wells; James I. (Canterbury, GB2) |
| Assignee: | Pfizer Inc. (New York, NY) |
| Application Number: | 07/256,938 |
| Patent Claims: |
1. The besylate salt of amlodipine.
2. A pharmaceutical composition comprising an antihypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine as claimed in claim 1 together with a pharmaceutically acceptable diluent or carrier. 3. A tablet formulation comprising an anti-hypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine as claimed in claim 1 in admixture with excipients. 4. A tablet formulation as claimed in claim 3 wherein the excipients comprise a compression and, an additive to provide sheen to the tablet, a disintegrant and a lubricant. 5. A tablet formulation as claimed in claim 4 wherein the excipients comprise microcrystalline cellulose, anhydrous dibasic calcium phosphate, sodium starch glycollate and magnesium stearate. 6. A capsule formulation comprising an antihypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine as claimed in claim 1 in admixture with excipients. 7. A capsule formulation as claimed in claim 6 wherein the excipients comprise an inert diluent, a dried disintegrant and a lubricant. 8. A capsule formulation as claimed in claim 7 wherein the excipients comprise microcrystalline cellulose, dried maize starch and magnesium stearate. 9. A sterile aqueous solution comprising an antihypertensive, antiischaemic or angina - alleviating effective amount of the besylate salt of amlodipine for parenteral administration. 10. A sterile aqueous solution as claimed in claim 9 comprising from 10 to 40% w/v of propylene glycol. 11. A sterile aqueous solution as claimed in claim 9 or claim 10 comprising about 1% w/v sodium chloride. |
